Trademark: 98067096
Word
TEMPUS
Status
Pending
Status Code
686
Status Date
Tuesday, February 27, 2024
Serial Number
98067096
Mark Type
3000
Filing Date
Friday, June 30, 2023
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
TEMPUS AI, INC. - Owner At Publication
Tempus Labs, Inc. - Original Applicant

Classifications
9 Downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology; downloadable and recorded computer software using artificial intelligence for machine learning for supporting clinical data platforms for cardiac diagnostics and electrophysiology
44 Medical services; providing an Internet website portal featuring patient health information in the fields of electrophysiology and cardiology; medical services in the fields of cardiology and electrophysiology diagnostics and testing
42 Platform as a service (PAAS) featuring computer software platforms for medical access to patient health information; Providing a web site featuring technology that enables users to access patient health information; Software as a service (SAAS) services featuring software for medical access to patient health information; Platform as a service (PaaS) featuring computer software platforms for voice command and recognition software, speech to text conversion software, and voice-enabled software applications for information management in the field of electronic health records relating to cardiology; Providing temporary use of online non-downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Medical research; Software as a Service (SaaS) services featuring software for the review and analysis of medical images in the fields of radiology and pathology that provides actionable insights to add clinical value, improve diagnostic decision making, efficiency, and productivity, in the fields of cardiology; medical and scientific research in the field of cardiology; medical and scientific research and development services in the field of cardiology and electrophysiology; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (PAAS) featuring computer software platforms for operating cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring software for cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology and electrophysiology; platform as a service (PAAS) featuring computer software platforms employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology and electrophysiology; providing a website featuring on-line non-downloadable software that enables users to analyze genome sequences for disease assessment, prediction of medical and clinical outcomes, medical and clinical research, and drug development; computer system design for use in electrophysiology and cardiology diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of electrophysiology and cardiology diagnostics and testing; software as a service (SAAS) services featuring software for clinical decision support in the fields of electrophysiology and cardiology, diagnostics and testing; platform as a service (PAAS) featuring computer software platforms for clinical decision support in the fields of electrophysiology and cardiology diagnostics and testing
The mark consists of the word "TEMPUS" with a stylized "T" comprised of two rectangles, one square and one upside-down "L" shape, in which, collectively, give the appearance of the letter "T".
Color is not claimed as a feature of the mark.

Trademark Events
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Examiner's Amendment Entered
Jan 24, 2024
Notification Of Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment -Written
Jan 22, 2024
Teas/Email Correspondence Entered
Jan 21, 2024
Correspondence Received In Law Office
Jan 21, 2024
Teas Response To Office Action Received
Jan 17, 2024
Automatic Update Of Assignment Of Ownership
Nov 28, 2023
Teas Change Of Correspondence Received
Nov 28, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 28, 2023
Teas Change Of Owner Address Received
Oct 21, 2023
Notification Of Non-Final Action E-Mailed
Oct 21, 2023
Non-Final Action E-Mailed
Oct 21, 2023
Non-Final Action Written
Oct 18, 2023
Assigned To Examiner
Aug 3, 2023
Notice Of Design Search Code E-Mailed
Aug 2, 2023
New Application Office Supplied Data Entered
Jul 4, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24